Bausch & Lomb to acquire AcuFocus

Bausch & Lomb has agreed to purchase AcuFocus, a manufacturer of devices to treat cataracts, Orange County Business Journal reported Feb. 6. 

AcuFocus is the manufacturer of IC-8 Apthera, an intraocular lens that received approval from the U.S. Food and Drug Administration in July 2022. The lens was commercially released in January. 

"Bausch & Lomb is a legacy name in eyecare with a fully integrated portfolio of offerings in eye health," Al Waterhouse, president and CEO of AcuFocus, said in a statement obtained by the publication. "We believe Bausch & Lomb is best positioned to educate physicians about the IC-8 Apthera lens, and ultimately, ensure more cataract patients have access to this new IOL."

AcuFocus has raised over $180 million since it was founded in 2001. 

Terms of the sale have not been disclosed.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast